TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2008: -$89.09M2009: -$69.94M2010: $99.22M2011: -$141.68M2012: -$74.61M2013: $588.60M2014: $752.43M2015: $1.33B2016: $1.49B2017: $1.31B2018: $2.20B2019: $2.43B2020: $2.62B2021: $7.08B2022: $5.01B2023: $4.59B2024: $4.42B2025: $4.98B$4.98B
2008Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$4.98B+12.6%
2024$4.42B-3.8%
2023$4.59B-8.4%
2022$5.01B-29.2%
2021$7.08B+170.5%
2020$2.62B+7.7%
2019$2.43B+10.7%
2018$2.20B+67.9%
2017$1.31B-12.0%
2016$1.49B+11.7%
2015$1.33B+76.9%
2014$752.43M+27.8%
2013$588.60M+888.8%
2012-$74.61M+47.3%
2011-$141.68M-242.8%
2010$99.22M+241.9%
2009-$69.94M+21.5%
2008-$89.09M—